Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Site Management Organizations Market, 2021-2035
... 40% of the total investment made for the development of drug candidate is dedicated to clinical trials; this is equivalent to an expenditure of USD 78 billion annually. However, the conduct of such trials is ... Read More
-
Post-Traumatic Stress Disorder (PTSD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... Landscape combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace. Components of the report include - Disease Landscape Disease Overview Epidemiology Overview Treatment Overview ... Read More
-
Virtual Clinical Trials Market Share, Size, Trends, Industry Analysis Report, By Design (Observational Trials, Interventional Trials, and Expanded Access Trials); By Indication; By Phases; By Region; Segment Forecast, 2023 - 2032
... trials market size is expected to reach USD 28,544.08 million by 2032, according to a new study by Polaris Market Research. The report “Virtual Clinical Trials Market Share, Size, Trends, Industry Analysis Report, By Design ... Read More
-
Global Clinical Trial Imaging Supply, Demand and Key Producers, 2023-2029
... the forecast period (2023-2029). Global core clinical trial imaging manufacturers include Clario, ICON, McLaren, Calyx and BioTelemetry. The top 5 companies hold a share about 60%. North America is the largest market, with a share ... Read More
-
Global Clinical Trial Imaging Market 2023 by Company, Regions, Type and Application, Forecast to 2029
... million in 2022 and is forecast to a readjusted size of USD 2215.1 million by 2029 with a CAGR of 6.6% during review period. Medical imaging now plays a vital role in clinical trials. Reputation ... Read More
-
Uveitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
... Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Uveitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Uveitis. Report includes ... Read More
-
Celiac Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Celiac Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Global Neuropathic Pain Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029
... global Neuropathic Pain market reached a value of USD 9263.0 million in 2022. It’s expected that the market will achieve USD 12324.0 million by 2028, exhibiting a CAGR of 4.87% during the forecast period. Limitations ... Read More
-
Pulmonary Tuberculosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Pulmonary Tuberculosis Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Age Related Macular Degeneration Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
... Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Age Related Macular Degeneration Clinical trials scenario. This report provides top line data ... Read More
-
Dengue Fever Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Dengue Fever Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Systemic Sclerosis (Scleroderma) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Systemic Sclerosis (Scleroderma) Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Cytomegalovirus (HHV-5) Infections Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Cytomegalovirus (HHV-5) Infections Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Wet (Neovascular/Exudative) Macular Degeneration Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
... Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Wet (Neovascular / Exudative) Macular Degeneration Clinical trials scenario. This report ... Read More
-
Cerebral Palsy Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Cerebral Palsy Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Alopecia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
... Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Alopecia Clinical trials scenario. This report provides top line data relating to the clinical trials on Alopecia. Report includes ... Read More
-
AI in Clinical Trials Market (2nd Edition): AI Software and Service Providers, 2023-2035
... 2023 and expected to grow at compounded annual growth rate (CAGR) of 16% during the forecast period. The process of successfully developing a novel therapeutic intervention is both time and cost intensive. In fact, it ... Read More
-
Neuropathic Pain Market
... Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Neuropathic pain is a condition which involves pain caused due to damage or diseases ... Read More
-
Human Immunodeficiency Virus (HIV) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
... including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Human Immunodeficiency Virus (HIV) Tests pipeline products with comparative analysis of the products at various ... Read More
-
Australia Influenza Vaccine Market Assessment, By Vaccine Type [Inactivated Influenza Vaccine, Live Attenuated Influenza Vaccine], By Type of Influenza [Seasonal and Pandemic], By Formulation [Trivalent, Quadrivalent], By Technology [Egg-based, Cell culture and Recombinant], By Age group [Paediatric and Adult], By Route of Administration [Intra-Muscular Injection, Nasal Spray], By Distribution Channel [Hospital, Retail Pharmacies, Government Suppliers and Others], By Region, By Opportunities and Forecast, 2016-2030F
... group [Paediatric and Adult], By Route of Administration [Intra-Muscular Injection, Nasal Spray], By Distribution Channel [Hospital, Retail Pharmacies, Government Suppliers and Others], By Region, By Opportunities and Forecast, 2016-2030F Australia Influenza Vaccine Market size was ... Read More
-
Global Clinical Trials Matching Software Market 2023 by Company, Regions, Type and Application, Forecast to 2029
... USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while ... Read More
-
Global Clinical Trials Matching Software Supply, Demand and Key Producers, 2023-2029
... during the forecast period (2023-2029). This report studies the global Clinical Trials Matching Software demand, key companies, and key regions. This report is a detailed and comprehensive analysis of the world market for Clinical Trials ... Read More
-
Medical Countermeasures Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... global medical countermeasures market is experiencing a major breakthrough in the healthcare industry, driven by the increasing demand for accessible and effective medicines to combat uncertain outbreaks. With the need for robust and apt medical ... Read More
-
Geographic Atrophy
... MarketVue® includes a disease overview, epidemiology (US and EU5), current treatment, unmet needs, pipeline and access and reimbursement chapter. Topics covered in this report: • Disease overview: Review the disease pathophysiology and potential druggable targets ... Read More
-
Autism Spectrum Disorder (ASD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... 9.8 million diagnosed prevalent cases of ASD in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast. The current ASD market is highly genericized, with only two products approved by the FDA. The ASD ... Read More
Research Assistance
